HIV Seropositivity

"HIV Seropositivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).

Descriptor ID	D006679
MeSH Number(s)	C02.782.815.616.400.500 C02.800.801.400.500 C20.673.480.500
Concept/Terms	HIV Seropositivity HIV Seropositivity HIV Seropositivities Seropositivities, HIV Seropositivity, HIV AIDS Seropositivity AIDS Seropositivities Seropositivities, AIDS Seropositivity, AIDS Anti-HIV Positivity Anti HIV Positivity Anti-HIV Positivities Positivities, Anti-HIV Positivity, Anti-HIV HTLV-III Seropositivity HTLV III Seropositivity HTLV-III Seropositivities Seropositivities, HTLV-III Seropositivity, HTLV-III HIV Seroconversion HIV Seroconversions Seroconversion, HIV Seroconversions, HIV HTLV-III Seroconversion HTLV III Seroconversion HTLV-III Seroconversions Seroconversion, HTLV-III Seroconversions, HTLV-III AIDS Seroconversion AIDS Seroconversions Seroconversion, AIDS Seroconversions, AIDS HIV Antibody Positivity Antibody Positivities, HIV Antibody Positivity, HIV HIV Antibody Positivities Positivities, HIV Antibody Positivity, HIV Antibody

Below are MeSH descriptors whose meaning is more general than "HIV Seropositivity".

Diseases [C]
Virus Diseases [C02]
RNA Virus Infections [C02.782]
Retroviridae Infections [C02.782.815]
Lentivirus Infections [C02.782.815.616]
HIV Infections [C02.782.815.616.400]
HIV Seropositivity [C02.782.815.616.400.500]
Sexually Transmitted Diseases [C02.800]
Sexually Transmitted Diseases, Viral [C02.800.801]
HIV Infections [C02.800.801.400]
HIV Seropositivity [C02.800.801.400.500]
Immune System Diseases [C20]
Immunologic Deficiency Syndromes [C20.673]
HIV Infections [C20.673.480]
HIV Seropositivity [C20.673.480.500]

Below are MeSH descriptors whose meaning is related to "HIV Seropositivity".

Below are MeSH descriptors whose meaning is more specific than "HIV Seropositivity".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV Seropositivity" by people in this website by year, and whether "HIV Seropositivity" was a major or minor topic of these publications.

Bar chart showing 149 publications over 26 distinct years, with a maximum of 18 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	1	0	1
1998	3	0	3
1999	1	0	1
2001	1	0	1
2002	1	2	3
2003	2	2	4
2004	7	2	9
2005	17	1	18
2006	5	2	7
2007	7	4	11
2008	2	1	3
2009	10	4	14
2010	10	1	11
2011	3	1	4
2012	9	1	10
2013	8	4	12
2014	4	5	9
2015	3	3	6
2016	2	1	3
2017	2	3	5
2018	3	2	5
2019	1	2	3
2020	1	0	1
2022	1	0	1
2023	2	1	3

Below are the most recent publications written about "HIV Seropositivity" by people in Profiles.

Dwivedi R, Prakash P, Kumbhar BV, Balasubramaniam M, Dash C. HIV-1 capsid and viral DNA integration. mBio. 2024 Jan 16; 15(1):e0021222.

View in: PubMed
Lyons DE, Kumar P, Roan NR, Defechereux PA, Feschotte C, Lange UC, Murthy N, Sameshima P, Verdin E, Ake JA, Parsons MS, Nath A, Gianella S, Smith DM, Kallas EG, Villa TJ, Strange R, Mwesigwa B, Furler O'Brien RL, Nixon DF, Ndhlovu LC, Valente ST, Ott M. HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing. Viruses. 2023 10 28; 15(11).

View in: PubMed
Ogundiran AI, Chang T-L, Ivanov A, Kumari N, Nekhai S, Chandran PL. Shear-reversible clusters of HIV-1 in solution: stabilized by antibodies, dispersed by mucin. J Virol. 2023 10 31; 97(10):e0075223.

View in: PubMed
Coleman MI, Khan M, Gbodossou E, Diop A, DeBarros K, Duong H, Bond VC, Floyd V, Kondwani K, Montgomery Rice V, Villinger F, Powell MD. Identification of a Novel Anti-HIV-1 Protein from Momordica balsamina Leaf Extract. Int J Environ Res Public Health. 2022 11 18; 19(22).

View in: PubMed
Bal?n IC, Lopez-Rios J, Giguere R, Lentz C, Dolezal C, Cruz Torres C, Brown W, Crespo R, Sheinfil A, Tagliaferri Rael C, Febo I, Carballo-Di?guez A. Then We Looked at His Results: Men Who Have Sex With Men from New York City and Puerto Rico Report Their Sexual Partner's Reactions to Receiving Reactive HIV Self-Test Results. AIDS Behav. 2020 Sep; 24(9):2597-2605.

View in: PubMed
Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio Gonz?lez Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Her?clio SA, Clifford GM. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis. 2019 08; 19(8):880-891.

View in: PubMed
Balasubramaniam M, Zhou J, Addai A, Martinez P, Pandhare J, Aiken C, Dash C. PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex. J Virol. 2019 03 15; 93(6).

View in: PubMed
Oda R, Agsalda-Garcia M, Loi N, Kamada N, Milne C, Killeen J, Choi SY, Lim E, Acosta-Maeda T, Misra A, Shiramizu B. Raman-Enhanced Spectroscopy Distinguishes Anal Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Serodiscordant Couples. AIDS Res Hum Retroviruses. 2019 03; 35(3):287-294.

View in: PubMed
Nyambe N, Hoover S, Pinder LF, Chibwesha CJ, Kapambwe S, Parham G, Subramanian S. Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia. Afr J Reprod Health. 2018 Dec; 22(4):92-101.

View in: PubMed
Oda R, Shiramizu B, Agsalda-Garcia M, Kettlewell J, Wojna V. In Vitro Blood-Brain Barrier Modeling adapted for Peripheral Blood Mononuclear Cell Transmigration from HIV-Positive Patients for Clinical Research on Therapeutic Drug Intervention. P R Health Sci J. 2018 09; 37(3):155-159.

View in: PubMed

People

Explore

Similar Concepts

Top Journals